MedTrace Logo

PPI and Microbiome in Healthy Volunteers and Functional Dyspepsia

NCT03545243 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2020-09-28

No results posted yet for this study

Summary

Prospective interventional study of the effect of PPI on the duodenal microbiome in healthy volunteers and functional dyspepsia patients

Conditions

Interventions

DRUG

Pantoprazole 40mg

Peroral Pantoprazole 40mg once daily during 28 days

OTHER

PPI withdrawal

PPI withdrawal for 8 weeks

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Tim Vanuytsel, MD PhD · UZ Leuven

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2020-03-08
Completion
2020-09-22

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545243 on ClinicalTrials.gov